Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2527866rdf:typepubmed:Citationlld:pubmed
pubmed-article:2527866lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:2527866lifeskim:mentionsumls-concept:C0000768lld:lifeskim
pubmed-article:2527866lifeskim:mentionsumls-concept:C0010674lld:lifeskim
pubmed-article:2527866lifeskim:mentionsumls-concept:C0205245lld:lifeskim
pubmed-article:2527866pubmed:issue4lld:pubmed
pubmed-article:2527866pubmed:dateCreated1989-10-12lld:pubmed
pubmed-article:2527866pubmed:abstractTextThe role of B cells and regulatory T cells in the reduced in vitro IgG synthesis of cystic fibrosis (CF) patients was studied. Intact proportion, proliferation, and differentiation of B cells and reduced suppressor and helper T-cell function were found. To explore the T-cell defects further, CF sera or supernatant derived from Pseudomonas aeruginosa cultures (PA supernatant) was added to the relevant T helper- and suppressor-cell assays. Both CF sera derived from PA-positive patients and PA supernatant interfered with the appearance of interleukin 2 (IL-2) receptors and with the functional enhancement caused by exogenously added IL-2. PA-negative CF patients, however, also had functional T-cell defects and inhibitory sera, but these sera did not affect IL-2 pathways. Thus different serum factors and intrinsic T-cell defects in CF patients are suggested.lld:pubmed
pubmed-article:2527866pubmed:languageenglld:pubmed
pubmed-article:2527866pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2527866pubmed:citationSubsetIMlld:pubmed
pubmed-article:2527866pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2527866pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2527866pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2527866pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2527866pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2527866pubmed:statusMEDLINElld:pubmed
pubmed-article:2527866pubmed:monthJullld:pubmed
pubmed-article:2527866pubmed:issn0271-9142lld:pubmed
pubmed-article:2527866pubmed:authorpubmed-author:LahatNNlld:pubmed
pubmed-article:2527866pubmed:authorpubmed-author:IancuT CTClld:pubmed
pubmed-article:2527866pubmed:authorpubmed-author:RivlinJJlld:pubmed
pubmed-article:2527866pubmed:issnTypePrintlld:pubmed
pubmed-article:2527866pubmed:volume9lld:pubmed
pubmed-article:2527866pubmed:ownerNLMlld:pubmed
pubmed-article:2527866pubmed:authorsCompleteYlld:pubmed
pubmed-article:2527866pubmed:pagination287-95lld:pubmed
pubmed-article:2527866pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2527866pubmed:meshHeadingpubmed-meshheading:2527866-...lld:pubmed
pubmed-article:2527866pubmed:meshHeadingpubmed-meshheading:2527866-...lld:pubmed
pubmed-article:2527866pubmed:meshHeadingpubmed-meshheading:2527866-...lld:pubmed
pubmed-article:2527866pubmed:meshHeadingpubmed-meshheading:2527866-...lld:pubmed
pubmed-article:2527866pubmed:meshHeadingpubmed-meshheading:2527866-...lld:pubmed
pubmed-article:2527866pubmed:meshHeadingpubmed-meshheading:2527866-...lld:pubmed
pubmed-article:2527866pubmed:meshHeadingpubmed-meshheading:2527866-...lld:pubmed
pubmed-article:2527866pubmed:meshHeadingpubmed-meshheading:2527866-...lld:pubmed
pubmed-article:2527866pubmed:meshHeadingpubmed-meshheading:2527866-...lld:pubmed
pubmed-article:2527866pubmed:meshHeadingpubmed-meshheading:2527866-...lld:pubmed
pubmed-article:2527866pubmed:meshHeadingpubmed-meshheading:2527866-...lld:pubmed
pubmed-article:2527866pubmed:meshHeadingpubmed-meshheading:2527866-...lld:pubmed
pubmed-article:2527866pubmed:meshHeadingpubmed-meshheading:2527866-...lld:pubmed
pubmed-article:2527866pubmed:meshHeadingpubmed-meshheading:2527866-...lld:pubmed
pubmed-article:2527866pubmed:meshHeadingpubmed-meshheading:2527866-...lld:pubmed
pubmed-article:2527866pubmed:meshHeadingpubmed-meshheading:2527866-...lld:pubmed
pubmed-article:2527866pubmed:meshHeadingpubmed-meshheading:2527866-...lld:pubmed
pubmed-article:2527866pubmed:meshHeadingpubmed-meshheading:2527866-...lld:pubmed
pubmed-article:2527866pubmed:meshHeadingpubmed-meshheading:2527866-...lld:pubmed
pubmed-article:2527866pubmed:meshHeadingpubmed-meshheading:2527866-...lld:pubmed
pubmed-article:2527866pubmed:meshHeadingpubmed-meshheading:2527866-...lld:pubmed
pubmed-article:2527866pubmed:year1989lld:pubmed
pubmed-article:2527866pubmed:articleTitleFunctional immunoregulatory T-cell abnormalities in cystic fibrosis patients.lld:pubmed
pubmed-article:2527866pubmed:affiliationImmunology Unit, Carmel Hospital, Haifa, Israel.lld:pubmed
pubmed-article:2527866pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2527866pubmed:publicationTypeIn Vitrolld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2527866lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2527866lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2527866lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2527866lld:pubmed